These effects were partially attributable to atrophy with cognitive impairment, as has been widely reported previously, in contrast to the atrophy-independent effects of APOE on entorhinal microstructure observed among cognitively normal individuals. The gene discussed is APOE; the disease is Cognitive impairment.